Flow Cytometry Market

Flow Cytometry Market by Product (Analyzer, Sorter, Reagents, Consumables, Software), Technology, Application (Research, Clinical - Cancer Diagnostics, Hematology), End User (Academia, Research Labs, Pharma, Biotech, Hospitals) - Global Forecast to 2026

Report Code: BT 6015 Oct, 2021, by marketsandmarkets.com

[282 Pages Report] The flow cytometry market is expected to register a CAGR of 8.1% to reach USD 6.3 Billion in 2026 from USD 4.3 Billion in 2021. The growth of the flow cytometry market is largely driven by rising global incidence and prevalence of HIV/AIDS and cancer, growing adoption of flow cytometry techniques in research and academia, growing public-private initiatives in the fields of immunology and immuno-oncology research, technological advancements, and the increasing incorporation of AI platforms in flow cytometry workflows and advancements in flow cytometry software.

Flow Cytometry Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the Global Flow Cytometry Market

COVID-19 is an infectious disease caused by the most recently discovered novel Coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic. The World Health Organization (WHO) officially declared the outbreak of COVID-19 a pandemic. Countries have implemented various measures to control the spread of the disease, such as strict travel restrictions, imposing city-wide quarantines, curfews, lockdowns, construction of specialty hospitals, increasing medical aid, and ramping up COVID-19 testing. It is a perturbing matter for countries that had thought to have succeeded in controlling the spread of the virus are now experiencing a second wave of the COVID-19 pandemic, increasing the worldwide demand for a vaccine for the virus.

  • Coronavirus pushed researchers across the world to respond to the COVID-19 pandemic. Several studies have used flow cytometry to investigate how the immune system reacts to SARS-CoV-2. For instance:
  • Flow cytometry showed researchers that COVID-19 patients had reduced B-cell and T-cell frequencies compared to the recovered donors and healthy donors.
  • In another study, researchers developed a flow-cytometric bead array (C19BA) to assess seroconversion against SARS-CoV-2, taking advantage of the multiplex capability of this technology for the simultaneous interrogation of the presence of IgG and IgM antibodies against three viral antigens. This approach unraveled the presence of N-reactive antibodies in a cohort of samples collected before the pandemic, indicating that cross-reactivity against this conserved viral protein exists.

According to an interview conducted with the scientists of Thermo Fisher Scientific, inc. (US), the University of California asked for volunteers from researchers, nurses, and clinicians for a large project about studying the effects of SARS-CoV-2. The scientists used purified proteins and created antibody panels for flow cytometry using additional flow cytometry analyzers, such as the Attune NxT Flow Cytometer, to analyze blood samples.

Thus, the COVID-19 pandemic has positively impacted this market, as flow cytometry technology is used in several COVID-19 research studies to investigate how the immune system reacts to SARS-CoV-2.

Flow Cytometry Market Dynamics

Driver: Growing adoption of flow cytometry techniques in research and academia

Flow cytometry has emerged as a key tool for safety and exploratory purposes during the drug discovery and development processes. This tool is used right from pre-clinical trials to target identification and screening. Flow cytometry can analyze a large number of particles in a short period and provide statistically robust information about cell populations. These abilities, coupled with its multi-parametric approach, facilitate the adoption of flow cytometry in drug discovery and development processes in the pharmaceutical and biopharmaceutical industries.

Moreover, biomarker research has become an integral part of drug discovery and development. It provides valuable evidence to guide clinical decisions, assesses the pharmacodynamics of drugs, and supports drug filings with regulatory bodies. This also increases the market value and acceleration process of a drug. Flow cytometry is widely used in biomarker research to monitor the development and differentiation of cell populations, evaluate target engagement and biomarker expression in cells, and assess cell functions and signaling events.

A significant number of clinical trials are being conducted across the globe to develop novel therapeutics to address the rising disease burden. The growing number of clinical trials is augmented by public and private funding for various clinical trial projects. For instance,

  • In March 2021, Campus Bio Medico University and Teaching Hospital (Italy) has initiated a study, Flow Cytometry Analysis of Eosinophils in Severe Asthma Patients.
  • In May 2021, the Moscow Department of Health sponsored a study, The Evaluation of Cellular and Humoral Immunity to COVID-19 in Moscow Residents, in collaboration with Clinical City Hospital named after I.V. Davydovsky of Moscow Department of Healthcare, Moscow State University of Medicine and Dentistry, Moscow Institute of Physics and Technology, National Research Center for Hematology, State Research Center Institute of Immunology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, and
  • National Medical Research Center of Phthisiopulmonology and Infectious Diseases. The research aims to estimate the levels of cellular and humoral immunity to the acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among Moscow residents over 18 years old using flow cytometry and ELISA.

The increasing number of clinical trials, coupled with the adoption of flow cytometry for various research applications, is a key factor driving the growth of this market.

Restraints: Significant product costs

Most end users, such as clinical laboratories, large research facilities, and pharmaceutical companies, require a significant number of flow cytometry instruments to carry out multiple research studies simultaneously. This leads to a significant increase in the capital cost associated with the procurement and maintenance of these devices. Academic and research laboratories find it difficult to afford such instruments due to restricted budgets.

In addition, maintenance costs and several other indirect expenses result in an overall increase in the total cost of ownership of these instruments. Thus, high product installation costs and other related expenditures hinder the optimal adoption of flow cytometry instruments in clinical and research applications, especially in emerging nations. In addition, flow cytometry instruments are equipped with advanced features and functionalities, thus making them high-priced instruments. However, flow cytometry-based cell sorters are more expensive than cell analyzers. For instance, as of July 2020, the average cost of a flow cytometer varies between USD 100,000 to USD 500,000 for a single unit.

Additionally, the demand for high-priced flow cytometry instruments and reagents is restricted due to the end-user preference for alternative affordable cell and genomic analysis techniques (such as microscopy, spectroscopy, PCR, and NGS), especially among individual researchers, small CROs, and emerging pharmaceutical and biotechnology companies. Thus, both significant product pricing and the availability of alternative techniques are expected to restrain the growth of the flow cytometry market during the study period.

Opportunities: Growing market presence in the Asia Pacific region

Countries such as China, Japan, India, South Korea offer significant growth opportunities to major players operating in the global flow cytometry market. These growth opportunities can be attributed to the increasing research initiatives across key countries, low regulatory barriers, continuous improvements in healthcare infrastructures, growing patient population, rising healthcare expenditure, and strengthening distribution networks of market leaders in these regions. Moreover, regulatory policies in the Asia Pacific are more adaptive and business-friendly due to less stringent regulations and data requirements. This, along with increasing competition in mature markets, has further propelled key players in the flow cytometry market to focus on emerging countries. For instance, China has a strong healthcare infrastructure, a fast-paced economy, rising domestic demand, and public-private initiatives that support research. Similarly, India also faces an increasing prevalence of target diseases and has a fast-growing life science research industry.

In order to leverage the growth opportunities in these countries, players in the flow cytometry market are increasingly focused on enhancing their presence in emerging countries and expanding their regional product offerings by pursuing various growth strategies, including expansions, partnerships, and collaborations, among others.

  • In October 2019, Cytek Biosciences opened new offices in Japan to expand its global reach to sell its advanced flow cytometry systems.
  • In March 2019, Sysmex Corporation (Japan) and Bayer Yakuhin, Ltd. (Japan) collaborated to promote open innovation by utilizing each other’s lab facilities to augment R&D for drug discovery and diagnostic applications.

>Additionally, in December 2019, Cytek Biosciences (US) received approval from the China National Medical Products Administration (NMPA) for Class I IVD flow cytometry reagents across China for clinical diagnostic use in hospitals, laboratories, and clinics. Similarly, in September 2019, the company received approval from the China National Medical Products Administration (NMPA) for its Cytek Northern Lights flow cytometer for clinical diagnostic use in hospitals, laboratories, and clinics across China.

The growth potential offered by emerging countries, coupled with the strengthening product portfolio and distribution channel of key players, is expected to offer renewed growth opportunities for stakeholders active in the flow cytometry market during the study period.

Challenges: Complexities related to reagent development

Reagents such as antibodies, fixatives, permeabilization buffers, and dyes target molecules of interest. Currently, the number of reagents for studying cells from solid tissues is low; thus, there is a need to develop new reagents.

The development of a novel effective reagent, however, is a complex process and includes various challenges such as variations in the brightness of fluorochromes and expression levels of markers, issues related to the stability of some fluorochromes, and optical background issues (due to significant emission spillover from non-primary fluorescent reagents) (Source: Becton, Dickinson and Company – White Paper). Considering this, it can be concluded that the development of reagents (that have multicolor capabilities and provide high speed, sensitivity, and ease of use in flow cytometry processes) is one of the key challenges manufacturers face in the flow cytometry reagents market.

By technology, the cell-based flow cytometry segment accounted for the largest share of the flow cytometry market in 2020.

By technology, the global flow cytometry market is categorized into cell-based and bead-based flow cytometry. the cell-based flow cytometry segment accounted for the largest share of the flow cytometry market. Cell-based flow cytometry tests compound activity against molecular targets within the context of living cells, due to which they are increasingly being used in drug discovery processes. The availability of automated technologies, such as high-throughput flow cytometry for cell-based screening further drives the growth of the cell-based flow cytometry market

By product and service, the reagents and consumables segment accounted for the largest share of the flow cytometry market in 2020

On the basis of product and service, the market is categorized into reagents and consumables, instruments, services, software, and accessories. The reagents and consumables segment dominate the flow cytometry market. Factors such as the development and commercialization of high-quality application-specific reagents and assays and the continuous requirement of flow cytometry reagents by end users are expected to drive the growth of the reagents and consumables market in the coming years.

North America accounted for the largest share of the flow cytometry market in 2020.

Geographically, this market is classified into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2020, the global flow cytometry market is expected to be dominated by North America, followed by Europe. North America’s prominence in this market is mainly driven by key market players and the increasing R&D expenditure and federal funding in the region.

Flow Cytometry Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The prominent players in the flow cytometry market are Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), and Luminex Corporation (US). These companies have adopted both organic and inorganic growth strategies, such as product launches and acquisitions, to maintain their leading positions in the flow cytometry market.

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2019–2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD)

Segments covered

Technology, Product and Service, Application, End User, and Region

Geographies covered

North America (US & Canada), Europe (Germany, France, UK, Italy, Spain, and RoE), APAC (Japan, China, India, Australia, South Korea, and RoAPAC), Latin America (Brazil, Mexico, and RoLATAM), and the Middle East and Africa

Companies covered
(25 major players)

Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Luminex Corporation (US), Agilent Technologies, Inc. (US), Sony Group Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec GmbH (Germany), Enzo Biochem, Inc. (US), Sysmex Corporation (Japan), bioMιrieux S.A. (France), Cytonome/ ST, LLC (US), Sartorius AG (Germany), Cytek Biosciences, Inc. (US), Union Biometrica, Inc. (US), Apogee Flow Systems Ltd. (UK), Stratedigm, Inc. (US), NanoCellect Biomedical, Inc. (US), On-chip Biotechnologies, Co., Ltd. (Japan), NEXCELOM BIOSCIENCE LLC (US), BennuBio Inc. (US), ORFLO Technologies (US), Bay Biosciences Co., Ltd. (Japan), BioLegend, Inc. (US), and CytoBuoy B.V (Netherlands).

This research report categorizes the flow cytometry market based on technology, product and service, application, end user, and region.

By Technology

  • Cell-based Flow Cytometry
  • Bead-based Flow Cytometry

By Product and Service

  • Reagents and Consumables
  • Instruments
    • Cell Analyzers
      • High-range
      • Mid-range
      • Low-range
    • Cell Sorters
      • High-range
      • Mid-range
      • Low-range
  • Services
  • Software
  • Accessories

By Application

  • Research Applications
    • Pharmaceuticals and Biotechnology
      • Drug Discovery
      • Stem Cell Research
      • In Vitro Toxicity Testing
    • Immunology
    • Cell Sorting
    • Apoptosis
    • Cell Cycle Analysis
    • Cell Viability
    • Cell Counting
    • Other Research Applications
  • Clinical Applications
    • Cancer Diagnostics
    • Hematology
    • Autoimmune Diseases
    • Organ Transplantation
    • Other Clinical Applications
  • Industrial Applications

By End User

  • Academic & Research Institutes
  • Hospitals & Clinical Testing Laboratories
  • Pharmaceutical & Biotechnology Companies

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of the Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (Rest of LATAM)
  • Middle East and Africa

Recent Development

  • In June 2021, Thermo Fisher Scientific, Inc. (US) launched Attune CytPix Flow Cytometer, a benchtop instrument that helps researchers working in QA/QC or cell therapy applications to gather additional information about cells and the sample quality while running flow cytometry experiments without sacrificing speed or simplicity
  • In June 2021, Cytek Biosciences, Inc. (US) launched Cytek Aurora CS, a new high-dimensional benchtop cell sorter.
  • In March 2021, Danaher Corporation (US) launched CytoFLEX SRT Benchtop Cell Sorter on the principles of the CytoFLEX, which make multicolor applications accessible.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 36)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 FLOW CYTOMETRY MARKET SEGMENTATION
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY USED FOR THE STUDY
    1.5 STAKEHOLDERS
    1.6 LIMITATIONS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 41)
    2.1 RESEARCH DATA
           FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 2 FLOW CYTOMETRY MARKET: BREAKDOWN OF PRIMARIES
    2.2 MARKET ESTIMATION METHODOLOGY
           2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
                    2.2.1.1 Key industry insights
                               FIGURE 3 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2020
                               FIGURE 4 AVERAGE MARKET SIZE ESTIMATION, 2020
           2.2.2 USAGE-BASED MARKET ESTIMATION
                    FIGURE 5 MARKET SIZE ESTIMATION: FLOW CYTOMETRY MARKET
    2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
           FIGURE 6 FLOW CYTOMETRY MARKET: CAGR PROJECTIONS, 2021–2026
           FIGURE 7 FLOW CYTOMETRY MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    2.4 DATA TRIANGULATION METHODOLOGY
           FIGURE 9 FLOW CYTOMETRY MARKET: DATA TRIANGULATION
    2.5 RESEARCH ASSUMPTIONS
    2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 53)
    FIGURE 10 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
    FIGURE 11 FLOW CYTOMETRY MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    FIGURE 12 FLOW CYTOMETRY MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    FIGURE 13 FLOW CYTOMETRY MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 57)
    4.1 FLOW CYTOMETRY MARKET OVERVIEW
           FIGURE 14 TECHNOLOGICAL ADVANCEMENTS IN FLOW CYTOMETRY PRODUCTS TO SUPPORT MARKET GROWTH
    4.2 NORTH AMERICA: FLOW CYTOMETRY MARKET SHARE, BY TECHNOLOGY AND COUNTRY (2020)
           FIGURE 15 CELL-BASED FLOW CYTOMETRY ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN FLOW CYTOMETRY MARKET IN 2020
    4.3 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021 VS. 2026 (USD MILLION)
           FIGURE 16 CANCER DIAGNOSTIC APPLICATIONS WILL CONTINUE TO DOMINATE THE FLOW CYTOMETRY MARKET IN 2026
    4.4 FLOW CYTOMETRY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 17 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE FLOW CYTOMETRY MARKET FROM 2021 TO 2026

5 MARKET OVERVIEW (Page No. - 61)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 18 FLOW CYTOMETRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Rising global incidence and prevalence of HIV/AIDS and cancer
                               TABLE 1 INCIDENCE OF HIV/AIDS, BY REGION, 2020
                               TABLE 2 GLOBAL CANCER INCIDENCE, 2020 VS. 2040
                    5.2.1.2 Growing adoption of flow cytometry techniques in research and academia
                    5.2.1.3 Growing public-private initiatives in immunology and immuno-oncology research
                    5.2.1.4 Technological advancements
                               TABLE 3 IMPORTANT TECHNOLOGICAL ADVANCEMENTS IN THE FLOW CYTOMETRY MARKET DURING 2018–2021
                    5.2.1.5 Increasing incorporation of AI platforms in flow cytometry workflow and advancements in flow cytometry software
                               TABLE 4 IMPORTANT SOFTWARE-RELATED ADVANCEMENTS IN THE FLOW CYTOMETRY MARKET DURING 2018–2021
           5.2.2 RESTRAINTS
                    5.2.2.1 Significant product costs
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing market presence in the Asia Pacific region
                    5.2.3.2 Evolving pipeline for stem cell research
                               TABLE 5 NIH-ESTIMATED STEM CELL RESEARCH EXPENDITURE DATA
                    5.2.3.3 Adoption of recombinant DNA technology for antibody production
                    5.2.3.4 Evolution of tandem flow cytometry technologies
           5.2.4 CHALLENGES
                    5.2.4.1 Complexities related to reagent development
                    5.2.4.2 Dearth of well-trained and skilled professionals
    5.3 IMPACT OF COVID-19 ON THE FLOW CYTOMETRY MARKET
    5.4 REGULATORY ASSESSMENT
           5.4.1 STRINGENT FDA REQUIREMENTS
           5.4.2 STRINGENT ANALYTE-SPECIFIC REAGENT RULE
           5.4.3 LACK OF WELL-DEFINED VALIDATION PROTOCOLS FOR CELL-BASED ASSAYS
           5.4.4 ABSENCE OF ESTABLISHED LABORATORY-DEVELOPED TEST GUIDELINES ON CELL-BASED FLUORESCENCE ASSAYS
           5.4.5 GREATER GLOBAL RECOGNITION FOR IVD CE MARK APPROVALS
           5.4.6 US REIMBURSEMENT SCENARIO
    5.5 PATENT ANALYSIS
           5.5.1 NUMBER OF PUBLICATIONS OVER THE LAST 10 YEARS
           5.5.2 TOP PATENT OWNERS IN THE LAST 20 YEARS
           5.5.3 TOP 10 PLAYERS WITH THE HIGHEST NUMBER OF PATENT APPLICATIONS
           5.5.4 LIST OF RECENT PATENTS
    5.6 SUPPLY CHAIN ANALYSIS
           FIGURE 19 DIRECT DISTRIBUTION STRATEGY PREFERRED BY PROMINENT COMPANIES
           5.6.1 KEY INFLUENCERS
    5.7 VALUE CHAIN ANALYSIS
           FIGURE 20 FLOW CYTOMETRY MARKET: VALUE CHAIN ANALYSIS
    5.8 ECOSYSTEM ANALYSIS OF THE FLOW CYTOMETRY MARKET
           FIGURE 21 ECOSYSTEM ANALYSIS OF THE FLOW CYTOMETRY MARKET
           5.8.1 ROLE IN THE ECOSYSTEM
    5.9 PORTER’S FIVE FORCES ANALYSIS
           TABLE 6 FLOW CYTOMETRY MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.9.1 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
           5.9.2 BARGAINING POWER OF SUPPLIERS
           5.9.3 BARGAINING POWER OF BUYERS
           5.9.4 THREAT OF SUBSTITUTES
           5.9.5 THREAT OF NEW ENTRANTS
    5.10 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS
           FIGURE 22 TRENDS AND DISRUPTIONS IN THE FLOW CYTOMETRY MARKET
    5.11 RANGES/SCENARIOS
                    FIGURE 23 DEPENDING ON HOW THE UNCERTAINTIES UNFOLD, WE SEE A SPECTRUM OF SCENARIOS FOR THE FLOW CYTOMETRY MARKET – 2020
    5.12 TRADE DATA
                    TABLE 7 IMPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2016–2020 (USD THOUSAND)
                               TABLE 8 EXPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2016–2020 (USD THOUSAND)

6 FLOW CYTOMETRY MARKET, BY TECHNOLOGY (Page No. - 83)
    6.1 INTRODUCTION
           TABLE 9 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
    6.2 CELL-BASED FLOW CYTOMETRY
           6.2.1 RESEARCH & DEVELOPMENT ON NOVEL THERAPEUTIC AGENTS WILL DRIVE THE GROWTH OF THE CELL-BASED FLOW CYTOMETRY MARKET
                    TABLE 10 CELL-BASED FLOW CYTOMETRY MARKET, BY REGION, 2019–2026 (USD MILLION)
    6.3 BEAD-BASED FLOW CYTOMETRY
           6.3.1 PROCEDURAL ADVANTAGES OF BEAD-BASED FLOW CYTOMETRY HAVE DRIVEN MARKET GROWTH
                    TABLE 11 BEAD-BASED FLOW CYTOMETRY MARKET, BY REGION, 2019–2026 (USD MILLION)

7 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE (Page No. - 87)
    7.1 INTRODUCTION
           TABLE 12 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
    7.2 REAGENTS & CONSUMABLES
           7.2.1 CONTINUOUS REQUIREMENT OF FLOW CYTOMETRY REAGENTS BY END USERS TO DRIVE MARKET GROWTH
                    TABLE 13 FLOW CYTOMETRY REAGENTS & CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 14 FLOW CYTOMETRY REAGENTS & CONSUMABLES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 15 FLOW CYTOMETRY REAGENTS & CONSUMABLES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 16 FLOW CYTOMETRY REAGENTS & CONSUMABLES MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 17 FLOW CYTOMETRY REAGENTS & CONSUMABLES MARKET, BY END USER, 2019–2026 (USD MILLION)
    7.3 INSTRUMENTS
           TABLE 18 FLOW CYTOMETRY INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
           TABLE 19 FLOW CYTOMETRY INSTRUMENTS MARKET, BY REGION, 2019–2026 (UNITS)
                    TABLE 20 FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 21 FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (UNITS)
                    TABLE 22 FLOW CYTOMETRY INSTRUMENTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 23 FLOW CYTOMETRY INSTRUMENTS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 24 FLOW CYTOMETRY INSTRUMENTS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 25 FLOW CYTOMETRY INSTRUMENTS MARKET, BY END USER, 2019–2026 (USD MILLION)
           7.3.1 CELL ANALYZERS
                    TABLE 26 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 27 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY REGION, 2019–2026 (UNITS)
                    TABLE 28 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY PRICE RANGE, 2019–2026 (USD MILLION)
                    TABLE 29 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 30 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 31 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 32 FLOW CYTOMETRY-BASED CELL ANALYZERS MARKET, BY END USER, 2019–2026 (USD MILLION)
                    7.3.1.1 High-range cell analyzers
                               7.3.1.1.1 Wide adoption of high-range cell analyzers among end users owing to their advantages to drive market growth
                               TABLE 33 HIGH-RANGE CELL ANALYZERS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    7.3.1.2 Mid-range cell analyzers
                               7.3.1.2.1 Wide availability of compact and high-performance analyzers to support market growth
                               TABLE 34 MID-RANGE CELL ANALYZERS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    7.3.1.3 Low-range cell analyzers
                               7.3.1.3.1 Low-range analyzers find significant adoption among price-sensitive end users
                               TABLE 35 LOW-RANGE CELL ANALYZERS MARKET, BY REGION, 2019–2026 (USD MILLION)
           7.3.2 CELL SORTERS
                    TABLE 36 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 37 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY REGION, 2019–2026 (USD UNITS)
                    TABLE 38 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY PRICE RANGE, 2019–2026 (USD MILLION)
                    TABLE 39 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 40 FLOW CYTOMETRY-BASED CELL SORTERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 41 FLOW CYTOMETRY-BASED CELL SORTERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 42 FLOW CYTOMETRY-BASED CELL SORTERS MARKET, BY END USER, 2019–2026 (USD MILLION)
                    7.3.2.1 High-range cell sorters
                               7.3.2.1.1 High cost and budgetary limitations among end users to restrain market growth to a certain extent
                               TABLE 43 HIGH-RANGE CELL SORTERS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    7.3.2.2 Mid-range cell sorters
                               7.3.2.2.1 Product launches and the cost-efficiency of mid-range sorters have enabled the growth of this market segment
                               TABLE 44 MID-RANGE CELL SORTERS MARKET, BY REGION, 2019–2026 (USD MILLION)
                    7.3.2.3 Low-range cell sorters
                               7.3.2.3.1 Small-scale labs and research facilities are the major end user of low-range sorters
                               TABLE 45 LOW-RANGE CELL SORTERS MARKET, BY REGION,  2019–2026 (USD MILLION)
    7.4 SERVICES
           7.4.1 REMOTE SERVICES ENSURE WORKFLOW CONTINUITY AND MAXIMIZE PERFORMANCE
                    TABLE 46 FLOW CYTOMETRY SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 47 FLOW CYTOMETRY SERVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 48 FLOW CYTOMETRY SERVICES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 49 FLOW CYTOMETRY SERVICES MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 50 FLOW CYTOMETRY SERVICES MARKET, BY END USER,  2019–2026 (USD MILLION)
    7.5 SOFTWARE
           7.5.1 AVAILABILITY OF A WIDE RANGE OF ANALYSIS SOFTWARE AND ADVANCEMENTS TO DRIVE MARKET GROWTH
                    TABLE 51 FLOW CYTOMETRY SOFTWARE MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 52 FLOW CYTOMETRY SOFTWARE MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 53 FLOW CYTOMETRY SOFTWARE MARKET FOR RESEARCH APPLICATIONS,  BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 54 FLOW CYTOMETRY SOFTWARE MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 55 FLOW CYTOMETRY SOFTWARE MARKET, BY END USER, 2019–2026 (USD MILLION)
    7.6 ACCESSORIES
           7.6.1 PROCEDURAL BENEFITS OFFERED BY ACCESSORIES AND AVAILABILITY OF ADVANCED FLOW CYTOMETRY ACCESSORIES ARE THE MAJOR FACTORS SUPPORTING MARKET GROWTH
                    TABLE 56 FLOW CYTOMETRY ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
                    TABLE 57 FLOW CYTOMETRY ACCESSORIES MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                    TABLE 58 FLOW CYTOMETRY ACCESSORIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 59 FLOW CYTOMETRY ACCESSORIES MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 60 FLOW CYTOMETRY ACCESSORIES MARKET, BY END USER, 2019–2026 (USD MILLION)

8 FLOW CYTOMETRY MARKET, BY APPLICATION (Page No. - 115)
    8.1 INTRODUCTION
           TABLE 61 FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
    8.2 RESEARCH APPLICATIONS
           TABLE 62 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 63 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
           8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY
                    TABLE 64 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
                    8.2.1.1 Drug discovery
                               8.2.1.1.1 Growing use of phenotypic cell-based assays in drug discovery to support market growth
                               TABLE 65 FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY, BY REGION, 2019–2026 (USD MILLION)
                    8.2.1.2 Stem cell research
                               8.2.1.2.1 Increasing investments in stem cell research to boost the adoption of flow cytometry instruments
                               TABLE 66 FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH, BY REGION,  2019–2026 (USD MILLION)
                    8.2.1.3 In vitro toxicity testing
                               8.2.1.3.1 Need to reduce the time and cost of drug development processes to drive market growth
                               TABLE 67 FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING, BY REGION, 2019–2026 (USD MILLION)
           8.2.2 IMMUNOLOGY
                    8.2.2.1 Increasing prevalence of infectious and autoimmune diseases to drive the demand for flow cytometry by research laboratories
                               TABLE 68 FLOW CYTOMETRY MARKET FOR IMMUNOLOGY APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
           8.2.3 CELL SORTING
                    8.2.3.1 Development of technologically advanced cell sorters to boost the market growth
                               TABLE 69 FLOW CYTOMETRY MARKET FOR CELL SORTING APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
           8.2.4 APOPTOSIS
                    8.2.4.1 Flow cytometry techniques are used to identify changes occurring during apoptosis
                               TABLE 70 FLOW CYTOMETRY MARKET FOR APOPTOSIS APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
           8.2.5 CELL CYCLE ANALYSIS
                    8.2.5.1 Chromosomal abnormalities can be detected using flow cytometry
                               TABLE 71 FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
           8.2.6 CELL VIABILITY
                    8.2.6.1 Cell viability is a key parameter studied using flow cytometry
                               TABLE 72 FLOW CYTOMETRY MARKET FOR CELL VIABILITY APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
           8.2.7 CELL COUNTING
                    8.2.7.1 Flow cytometry enables easy differentiation of cells via scattering or staining
                               TABLE 73 FLOW CYTOMETRY MARKET FOR CELL COUNTING APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
           8.2.8 OTHER RESEARCH APPLICATIONS
                    TABLE 74 FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
    8.3 CLINICAL APPLICATIONS
           TABLE 75 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 76 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
           8.3.1 CANCER DIAGNOSTICS
                    8.3.1.1 Flow cytometry tools are used to determine the malignancy of a tumor
                               TABLE 77 FLOW CYTOMETRY MARKET FOR CANCER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
           8.3.2 HEMATOLOGY
                    8.3.2.1 Flow cytometry identifies a wide range of cell surfaces and cytoplasmic antigens
                               TABLE 78 FLOW CYTOMETRY MARKET FOR HEMATOLOGY APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
           8.3.3 AUTOIMMUNE DISEASES
                    8.3.3.1 Flow cytometry helps in the diagnosis of primary immunodeficiencies
                               TABLE 79 FLOW CYTOMETRY MARKET FOR IMMUNODEFICIENCY DISEASE APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
           8.3.4 ORGAN &TISSUE TRANSPLANTATION
                    8.3.4.1 The use of flow cytometry to reduce organ rejection rates has contributed to market growth
                               TABLE 80 FLOW CYTOMETRY MARKET FOR ORGAN TRANSPLANTATION APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
           8.3.5 OTHER CLINICAL APPLICATIONS
                    TABLE 81 FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
    8.4 INDUSTRIAL APPLICATIONS
           8.4.1 A WIDE END-USER BASE WILL DRIVE MARKET GROWTH
                    TABLE 82 FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)

9 FLOW CYTOMETRY MARKET, BY END USER (Page No. - 133)
    9.1 INTRODUCTION
           TABLE 83 FLOW CYTOMETRY MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.2 ACADEMIC & RESEARCH INSTITUTES
           9.2.1 GROWING NUMBER OF RESEARCH PROJECTS THROUGH INDUSTRY-ACADEMIA COLLABORATIONS TO DRIVE MARKET GROWTH
                    TABLE 84 FLOW CYTOMETRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION)
    9.3 HOSPITALS & CLINICAL TESTING LABORATORIES
           9.3.1 RISING AWARENESS AND DISEASE PREVALENCE HAVE SUSTAINED THE DEMAND FOR FLOW CYTOMETERS IN HOSPITALS & CLINICAL TESTING LABS
                    TABLE 85 FLOW CYTOMETRY MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2019–2026 (USD MILLION)
    9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
           9.4.1 INCREASE IN DRUG DISCOVERY ACTIVITIES TO DRIVE MARKET GROWTH
                    TABLE 86 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION)

10 FLOW CYTOMETRY MARKET, BY REGION (Page No. - 138)
     10.1 INTRODUCTION
               TABLE 87 FLOW CYTOMETRY MARKET, BY REGION, 2019–2026 (USD MILLION)
     10.2 NORTH AMERICA
               FIGURE 24 NORTH AMERICA: FLOW CYTOMETRY MARKET SNAPSHOT
               TABLE 88 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
               TABLE 89 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
               TABLE 90 NORTH AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 91 NORTH AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (UNITS)
               TABLE 92 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
               TABLE 93 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
               TABLE 94 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.2.1 US
                       10.2.1.1 High prevalence of cancer, HIV-AIDS, and autoimmune disorders in the US to drive market growth
                                   TABLE 95 US: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                   TABLE 96 US: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 97 US: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,  2019–2026 (USD MILLION)
                                   TABLE 98 US: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                   TABLE 99 US: FLOW CYTOMETRY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.2.2 CANADA
                       10.2.2.1 Ongoing government initiatives to support life science research will boost the demand for flow cytometry products in Canada
                                   TABLE 100 CANADA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                   TABLE 101 CANADA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 102 CANADA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                   TABLE 103 CANADA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                   TABLE 104 CANADA: FLOW CYTOMETRY MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.3 EUROPE
               TABLE 105 EUROPE: FLOW CYTOMETRY MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
               TABLE 106 EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,  2019–2026 (USD MILLION)
               TABLE 107 EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 108 EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (UNITS)
               TABLE 109 EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
               TABLE 110 EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
               TABLE 111 EUROPE: FLOW CYTOMETRY MARKET, BY END USER,  2019–2026 (USD MILLION)
             10.3.1 GERMANY
                       10.3.1.1 Strong R&D infrastructure, training, and awareness programs ensure market growth in Germany
                                   TABLE 112 GERMANY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                   TABLE 113 GERMANY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 114 GERMANY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                   TABLE 115 GERMANY: FLOW CYTOMETRY MARKET, BY APPLICATION,  2019–2026 (USD MILLION)
                                   TABLE 116 GERMANY: FLOW CYTOMETRY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.2 UK
                       10.3.2.1 Growing acceptance of flow cytometry products for clinical diagnostics in the UK to drive market growth
                                   TABLE 117 UK: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                   TABLE 118 UK: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 119 UK: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                   TABLE 120 UK: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                   TABLE 121 UK: FLOW CYTOMETRY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.3 FRANCE
                       10.3.3.1 Increasing R&D spending and strong government funding for proteomics and genomics research to fuel the adoption of flow cytometry
                                   TABLE 122 FRANCE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                   TABLE 123 FRANCE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 124 FRANCE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                   TABLE 125 FRANCE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                   TABLE 126 FRANCE: FLOW CYTOMETRY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.4 ITALY
                       10.3.4.1 Increasing geriatric population and growing life science research activities to drive market demand in Italy
                                   TABLE 127 ITALY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                   TABLE 128 ITALY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 129 ITALY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                   TABLE 130 ITALY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                   TABLE 131 ITALY: FLOW CYTOMETRY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.5 SPAIN
                       10.3.5.1 Growing focus on cancer diagnosis is increasing the use of flow cytometry products in Spain
                                   TABLE 132 SPAIN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                   TABLE 133 SPAIN: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 134 SPAIN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                   TABLE 135 SPAIN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                   TABLE 136 SPAIN: FLOW CYTOMETRY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.3.6 REST OF EUROPE
                       TABLE 137 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                       TABLE 138 REST OF EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                       TABLE 139 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                       TABLE 140 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                       TABLE 141 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY END USER,  2019–2026 (USD MILLION)
     10.4 ASIA PACIFIC
               FIGURE 25 ASIA PACIFIC: FLOW CYTOMETRY MARKET SNAPSHOT
               TABLE 142 APAC: FLOW CYTOMETRY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
               TABLE 143 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
               TABLE 144 ASIA PACIFIC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 145 ASIA PACIFIC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (UNITS)
               TABLE 146 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
               TABLE 147 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
               TABLE 148 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.1 JAPAN
                       10.4.1.1 Growing flow cytometry-based research activities to drive market growth in Japan
                                   TABLE 149 JAPAN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                   TABLE 150 JAPAN: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 151 JAPAN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                   TABLE 152 JAPAN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                   TABLE 153 JAPAN: FLOW CYTOMETRY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.2 CHINA
                       10.4.2.1 High incidence of target diseases and growing presence of global players to drive market growth in China
                                   TABLE 154 CHINA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                   TABLE 155 CHINA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE,  2019–2026 (USD MILLION)
                                   TABLE 156 CHINA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                   TABLE 157 CHINA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                   TABLE 158 CHINA: FLOW CYTOMETRY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.3 INDIA
                       10.4.3.1 Increasing pharma R&D and strong government funding in the biotechnology industry to drive market growth in India
                                   TABLE 159 INDIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                   TABLE 160 INDIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 161 INDIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                   TABLE 162 INDIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                   TABLE 163 INDIA: FLOW CYTOMETRY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.4 AUSTRALIA
                       10.4.4.1 Rising cancer prevalence and increasing government initiatives to drive market growth in Australia
                                   TABLE 164 AUSTRALIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE,  2019–2026 (USD MILLION)
                                   TABLE 165 AUSTRALIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 166 AUSTRALIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY,  2019–2026 (USD MILLION)
                                   TABLE 167 AUSTRALIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                   TABLE 168 AUSTRALIA: FLOW CYTOMETRY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.4.5 SOUTH KOREA
                       10.4.5.1 Strong government support for the biotechnology industry and rising awareness of flow cytometry to drive the South Korean market
                                   TABLE 169 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                   TABLE 170 SOUTH KOREA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 171 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                   TABLE 172 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                   TABLE 173 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY END USER,  2019–2026 (USD MILLION)
             10.4.6 REST OF ASIA PACIFIC
                       TABLE 174 ROAPAC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                       TABLE 175 ROAPAC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                       TABLE 176 ROAPAC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                       TABLE 177 ROAPAC: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                       TABLE 178 ROAPAC: FLOW CYTOMETRY MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.5 LATIN AMERICA
               TABLE 179 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
               TABLE 180 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
               TABLE 181 LATIN AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
               TABLE 182 LATIN AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (UNITS)
               TABLE 183 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
               TABLE 184 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
               TABLE 185 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.5.1 BRAZIL
                       10.5.1.1 Brazil dominates the Latin American flow cytometry market
                                   TABLE 186 BRAZIL: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                   TABLE 187 BRAZIL: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 188 BRAZIL: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                   TABLE 189 BRAZIL: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                   TABLE 190 BRAZIL: FLOW CYTOMETRY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.5.2 MEXICO
                       10.5.2.1 Favorable trade agreements to support imports and accessibility to flow cytometry products in Mexico
                                   TABLE 191 MEXICO: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                   TABLE 192 MEXICO: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                   TABLE 193 MEXICO: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                                   TABLE 194 MEXICO: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                                   TABLE 195 MEXICO: FLOW CYTOMETRY MARKET, BY END USER, 2019–2026 (USD MILLION)
             10.5.3 REST OF LATIN AMERICA
                       TABLE 196 ROLA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                       TABLE 197 ROLA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                       TABLE 198 ROLA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                       TABLE 199 ROLA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                       TABLE 200 ROLA: FLOW CYTOMETRY MARKET, BY END USER, 2019–2026 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA
             10.6.1 FUNDING INITIATIVES AND STRATEGIC PARTNERSHIPS IN THE RESEARCH SECTOR TO DRIVE MARKET GROWTH
                       TABLE 201 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                       TABLE 202 MIDDLE EAST & AFRICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                       TABLE 203 MIDDLE EAST & AFRICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (UNITS)
                       TABLE 204 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
                       TABLE 205 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
                       TABLE 206 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY END USER, 2019–2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 198)
     11.1 INTRODUCTION
     11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
               FIGURE 26 FLOW CYTOMETRY MARKET: STRATEGIES ADOPTED
     11.3 MARKET SHARE ANALYSIS
               FIGURE 27 FLOW CYTOMETRY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
               TABLE 207 FLOW CYTOMETRY MARKET: DEGREE OF COMPETITION
     11.4 COMPANY EVALUATION QUADRANT
             11.4.1 STARS
             11.4.2 EMERGING LEADERS
             11.4.3 PERVASIVE PLAYERS
             11.4.4 PARTICIPANTS
                       FIGURE 28 FLOW CYTOMETRY MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
     11.5 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/START-UPS (2020)
             11.5.1 PROGRESSIVE COMPANIES
             11.5.2 STARTING BLOCKS
             11.5.3 RESPONSIVE COMPANIES
             11.5.4 DYNAMIC COMPANIES
                       FIGURE 29 FLOW CYTOMETRY MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS, 2020
     11.6 COMPETITIVE BENCHMARKING
             11.6.1 COMPANY FOOTPRINT
                       TABLE 208 COMPANY PRODUCT FOOTPRINT
                       TABLE 209 COMPANY REGIONAL FOOTPRINT
     11.7 COMPETITIVE SCENARIO AND TRENDS
             11.7.1 PRODUCT LAUNCHES
                       TABLE 210 FLOW CYTOMETRY MARKET: PRODUCT LAUNCHES, JANUARY 2018–JULY 2021
             11.7.2 DEALS
                       TABLE 211 FLOW CYTOMETRY MARKET: DEALS, JANUARY 2018–JULY 2021

12 COMPANY PROFILES (Page No. - 211)
     12.1 KEY COMPANIES
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             12.1.1 BECTON, DICKINSON AND COMPANY
                       TABLE 212 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
                       FIGURE 30 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
                       TABLE 213 BECTON, DICKINSON AND COMPANY: PRODUCT/SERVICE OFFERINGS
                       TABLE 214 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS
             12.1.2 DANAHER CORPORATION
                       TABLE 215 DANAHER CORPORATION: BUSINESS OVERVIEW
                       FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
                       TABLE 216 DANAHER CORPORATION: PRODUCT/SERVICE OFFERINGS
                       TABLE 217 DANAHER CORPORATION: PRODUCT LAUNCHES AND ENHANCEMENTS
                       TABLE 218 DANAHER CORPORATION: DEALS
             12.1.3 THERMO FISHER SCIENTIFIC, INC.
                       TABLE 219 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
                       FIGURE 32 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2020)
                       TABLE 220 THERMO FISHER SCIENTIFIC, INC.: PRODUCT/SERVICE OFFERINGS
                       TABLE 221 THERMO FISHER SCIENTIFIC, INC.: PRODUCT LAUNCHES AND ENHANCEMENTS
                       TABLE 222 THERMO FISHER SCIENTIFIC, INC.: DEALS
             12.1.4 AGILENT TECHNOLOGIES, INC.
                       TABLE 223 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
                       FIGURE 33 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2020)
                       TABLE 224 AGILENT TECHNOLOGIES, INC.: PRODUCT OFFERINGS
                       TABLE 225 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES
                       TABLE 226 AGILENT TECHNOLOGIES, INC.: DEALS
             12.1.5 SONY BIOTECHNOLOGY INC. (A SUBSIDIARY OF SONY GROUP CORPORATION)
                       TABLE 227 SONY GROUP CORPORATION: BUSINESS OVERVIEW
                       FIGURE 34 SONY GROUP CORPORATION: COMPANY SNAPSHOT (2020)
                       TABLE 228 SONY BIOTECHNOLOGY INC.: PRODUCT/SERVICE OFFERINGS
             12.1.6 BIO-RAD LABORATORIES, INC.
                       TABLE 229 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
                       FIGURE 35 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2020)
                       TABLE 230 BIO-RAD LABORATORIES, INC.: PRODUCT/SERVICE OFFERINGS
                       TABLE 231 BIO-RAD LABORATORIES, INC.: DEALS
             12.1.7 MILTENYI BIOTEC
                       TABLE 232 MILTENYI BIOTEC: BUSINESS OVERVIEW
                       TABLE 233 MILTENYI BIOTEC: PRODUCT/SERVICE OFFERINGS
                       TABLE 234 MILTENYI BIOTEC: PRODUCT LAUNCHES
             12.1.8 ENZO BIOCHEM, INC.
                       TABLE 235 ENZO BIOCHEM, INC.: BUSINESS OVERVIEW
                       FIGURE 36 ENZO BIOCHEM, INC.: COMPANY SNAPSHOT (2020)
                       TABLE 236 ENZO BIOCHEM, INC.: PRODUCT OFFERINGS
             12.1.9 SYSMEX CORPORATION
                       TABLE 237 SYSMEX CORPORATION: BUSINESS OVERVIEW
                       FIGURE 37 SYSMEX CORPORATION: COMPANY SNAPSHOT (2020)
                       TABLE 238 SYSMEX CORPORATION: PRODUCT/SERVICE OFFERINGS
                       TABLE 239 SYSMEX CORPORATION: PRODUCT LAUNCHES
             12.1.10 BIOMΙRIEUX SA
                       TABLE 240 BIOMΙRIEUX SA: BUSINESS OVERVIEW
                       FIGURE 38 BIOMΙRIEUX SA: COMPANY SNAPSHOT (2020)
                       TABLE 241 BIOMΙRIEUX SA: PRODUCT/SERVICE OFFERINGS
             12.1.11 CYTONOME/ST, LLC.
                       TABLE 242 CYTONOME/ST, LLC: BUSINESS OVERVIEW
                       TABLE 243 CYTONOME/ST, LLC: PRODUCT OFFERINGS
             12.1.12 SARTORIUS AG
                       TABLE 244 SARTORIUS AG: BUSINESS OVERVIEW
                       FIGURE 39 SARTORIUS AG: COMPANY SNAPSHOT (2020)
                       TABLE 245 SARTORIUS AG: PRODUCT OFFERINGS
                       TABLE 246 SARTORIUS AG: PRODUCT LAUNCHES/UPGRADES
             12.1.13 CYTEK BIOSCIENCES
                       TABLE 247 CYTEK BIOSCIENCES: BUSINESS OVERVIEW
                       TABLE 248 CYTEK BIOSCIENCES: PRODUCT/SERVICE OFFERINGS
                       TABLE 249 CYTEK BIOSCIENCES: PRODUCT LAUNCHES/APPROVALS
                       TABLE 250 CYTEK BIOSCIENCES: DEALS
                       TABLE 251 CYTEK BIOSCIENCES: OTHER DEVELOPMENTS
             12.1.14 UNION BIOMETRICA, INC.
                       TABLE 252 UNION BIOMETRICA, INC.: BUSINESS OVERVIEW
                       TABLE 253 UNION BIOMETRICA, INC.: PRODUCT/SERVICE OFFERINGS
             12.1.15 LUMINEX CORPORATION
                       TABLE 254 LUMINEX CORPORATION: BUSINESS OVERVIEW
                       FIGURE 40 LUMINEX CORPORATION: COMPANY SNAPSHOT (2020)
                       TABLE 255 LUMINEX CORPORATION: PRODUCT/SERVICE OFFERINGS
                       TABLE 256 LUMINEX CORPORATION: DEALS
     12.2 START-UP PLAYERS
             12.2.1 APOGEE FLOW SYSTEMS LTD.
                       TABLE 257 APOGEE FLOW SYSTEMS LTD.: BUSINESS OVERVIEW
                       TABLE 258 APOGEE FLOW SYSTEMS LTD.: PRODUCT/SERVICE OFFERINGS
                       TABLE 259 APOGEE FLOW SYSTEMS LTD.: PRODUCT LAUNCHES/UPGRADES
             12.2.2 STRATEDIGM, INC.
                       TABLE 260 STRATEDIGM, INC.: BUSINESS OVERVIEW
                       TABLE 261 STRATEDIGM, INC.: PRODUCT/SERVICE OFFERINGS
                       TABLE 262 STRATEDIGM, INC.: PRODUCT LAUNCHES/UPGRADES
                       TABLE 263 STRATEDIGM, INC.: DEALS
             12.2.3 NANOCELLECT BIOMEDICAL, INC.
             12.2.4 ON-CHIP BIOTECHNOLOGIES CO., LTD.
             12.2.5 NEXCELOM BIOSCIENCE LLC.
             12.2.6 BENNUBIO INC.
             12.2.7 ORFLO TECHNOLOGIES
             12.2.8 BAY BIOSCIENCE CO., LTD.
             12.2.9 CYTOBUOY B.V.
             12.2.10 BIOLEGEND, INC.

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 274)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This research study involved four major activities to estimate the current size of the global flow cytometry market. Exhaustive secondary research was done to collect information on the market and subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

In secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold standard & silver standard websites, regulatory bodies, and databases (such as D&B, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

The flow cytometry market comprises several stakeholders, such as flow cytometry product manufacturers, suppliers and distributors, healthcare service providers, and academic and research institutes. The demand side of this market is characterized by the growing demand for compact, high-throughput, and affordable flow cytometry instruments. The supply side is characterized by advancements in technology. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. A breakdown of primary respondents follows:

Flow Cytometry Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the flow cytometry market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the flow cytometry industry.

Report Objectives

  • To define, describe, and forecast the flow cytometry market by technology, product & service, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the flow cytometry market (drivers, restraints, opportunities, and challenges) along with the current trends
  • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall flow cytometry market
  • To analyze opportunities in the global flow cytometry market for key stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the market value data of various market segments and sub-segments with respect to five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile key global players and comprehensively analyze their market shares and core competencies2
  • To track and analyze competitive developments such as product developments and acquisitions in the global flow cytometry market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the client’s specific needs. The following customization options are available for the present global flow cytometry market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies in the flow cytometry market

Company Information

  • Detailed analysis and profiling of additional market companies (up to five)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Flow Cytometry Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Flow Cytometry Market

Request For Special Pricing
Report Code
BT 6015
Published ON
Oct, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Flow Cytometry Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved